Business news from Ukraine

UKRAINE NEEDS TIME TO LAUNCH QR CODES FOR MEDICINES – BORSCHAHIVKA PHARMACEUTICAL PLANT

The Ukrainian market needs three or five years to fully launch the QR code system for packages of medicines, Commercial Director of Research and Industrial Center Borschahivka chemical and pharmaceutical plant Yevhen Sova has said. “The implementation of the new rules is a step in right direction, but it is a long process, which should be prepared and introduced in phases. The Ukrainian market would require from three to five years to organically introduce the changes,” he told Interfax-Ukraine.
Sova said that the introduction of QR codes for packages would allow helping in fight against counterfeit medicines.
“We are preparing for this at Borschahivka chemical and pharmaceutical plant. The enterprise has installed specialized equipment for placing QR codes on packages,” he said.
The expert said that the monitoring system using QR codes would work only the general public approach at all levels of flow of medicines would apply.
Sova said that the introduction of QR codes on the Ukrainian pharmaceutical market could affect the cost of medicines.

, ,

BORSCHAHIVKA PHARMACEUTICAL PLANT FILES LAWSUIT AGAINST DARNITSA PHARMA

PJSC Research and Industrial Center Borschahivka chemical and pharmaceutical plant has filed a lawsuit to Kyiv’s business court against PrJSC Darnitsa pharmaceutical firm (both based in Kyiv) and a lawsuit against the municipal ownership department of the Kyiv City Council, seeking to declare invalid a trading session where shares in the plant were sold and the respective sale and purchase contract was signed. “After studying the materials of the lawsuit, the court declared them sufficient for accepting the lawsuit, opening the proceeding and hearing the case,” the business court said in a ruling published in the unified register of court rulings.
In turn, Darnitsa pharmaceutical firm filed the counterclaim against Borschahivka chemical and pharmaceutical plant seeking to declare valid its ownership rights to the shares of the plant.
Four persons also filed lawsuits to the business court of Kyiv with the same demands against Darnitsa pharmaceutical firm and the municipal ownership department of the Kyiv City Council.

, ,